Designed for more
Build the practice you want with a legacy platform designed to deliver more.
What Sets xeo+ Apart
Born from a 20+ year legacy where precision meets passion, xeo+ represents the next evolution in multi-platform technology. A tunable workstation combining laser and IPL, built for versatility and reliability across a wide range of aesthetic and dermatological concerns.
Laser and IPL in one platform, addressing skin revitalisation, vascular, pigment and hair reduction.
A wide range of handpieces to match your clinical requirements and patient base.
Cutera's signature treatment, delivered in 15 minutes or less with results that improve with each session.
Optimised ergonomics and a guided interface supporting confident, consistent delivery.
Customise your unit now and build upon it when you are ready to expand your offering.
Schedule your xeo+ practice consultation
See xeo+ in Action
Expand Your Aesthetic Horizons
Vascular
Pigmentation and photodamage
Signature treatment:
Hair reduction
Take the next step with xeo+
Reach for more in your practice
xeo+ offers a wide range of handpieces to address multiple aesthetic and dermatological concerns. Choose to customise your unit, and build upon it when you are ready to expand your offerings.
Precision spot treatment for unwanted reds and browns. Traces discrete vascular and pigmented lesions with accuracy, and is well suited to combination treatments alongside broader light-based protocols. For skin types I to IV.
Model. Not actual patient.
Reach for more in your practice
Twenty years of Nd:YAG heritage, refined into a platform built for how modern practices work. One workstation covering skin revitalisation, vascular, pigment and hair reduction, with Laser Genesis at its core and a range of handpieces you configure to your patient base.
Start with what your patients need today. Build on it when you are ready.
Schedule a Consultation
Indications for Use: The xeo+ 1064 nm is indicated for: removal of unwanted hair; stable long-term, or permanent hair reduction through selective targeting of melanin in hair follicles; treatment of pseudofolliculitis barbae (PFB); treatment of benign vascular lesions such as, but not limited to, hemangiomas, port wine stains, telangiectasias, rosacea, venous lakes, leg veins, spider veins and poikiloderma of Civatte; treatment of wrinkles such as, but not limited to, periocular and perioral wrinkles; reduction of red pigmentation in hypertrophic scars where vascularity is an integral part of the scar; treatment of warts; treatment of mild to moderate inflammatory acne vulgaris.
Contraindications: pregnant patients; patients undergoing treatment for skin cancer.
Important Safety Information: Expected Transient Events and Possible Adverse Effects: DISCOMFORT/PAIN – Some discomfort may be experienced during treatment. Pain may include the feeling of burning, stinging, and radiating pain. REDNESS/SWELLING – Short term redness (erythema) is common, and swelling (edema) of the treated area may occur. An urticarial (hive-like) reaction may occur with smaller vessels. PURPURA/BRUISING – Purpura (bruising) is a transient phenomenon that usually resolves with time. ITCHING/DRY SKIN – Treatment may result in itching and/or dry skin. RED RASH/BUMPS – Red rash/bumps may appear after treatment. This resolves with time. HEMOSIDERIN STAINING – Hemosiderin staining (iron leaking into tissue from blood breakdown) may occur and usually resolves over time; however, it may be permanent. HYPOPIGMENTATION/ HYPERPIGMENTATION – During the healing process, there is a slight possibility that the treated area may become either lighter (hypopigmentation) or darker (hyperpigmentation) in color compared to the surrounding skin. This is usually temporary, but, on a rare occasion, it may be permanent. EPIDERMAL CRUSTING – Pigmented lesions may crust as part of the healing process. Epidermal crusting may develop over vascular lesions. It is important not to disturb the crusts. Crusts will typically slough 7 to 14 days after treatment but may require medication if sensitivity or redness occurs. WOUNDS – Treatment can result in burning, blistering, or bleeding of the treated areas. When treating warts, deep tissue injury and prolonged wound healing may also occur. INFECTION – Infection is a rare possibility whenever the skin surface is disrupted, though proper wound care should prevent this.
If signs of infection develop, such as pain, heat or surrounding redness, the patient should be advised to contact their treatment provider. SCARRING – Scarring is a rare occurrence, but it is a possibility if the skin’s surface is disrupted. To minimize the chances of scarring, it is important to advise patients to follow all post-treatment instructions.TEXTURAL CHANGES/CUTANEOUS INDENTATIONS – Textural changes and/or cutaneous indentations may occur as a result of heat diffusion and thermal injury to tissue surrounding vessels. UNDESIRABLE HAIR REDUCTION – Hair reduction may occur at treatment sites not intended for hair reduction, such as during vascular or laser genesis treatments. This is usually temporary but may be permanent. PARADOXICAL HAIR GROWTH – Stimulation of terminal hair growth following photo- epilation may occur within or adjacent to the treated area. LEUKOTRICHIA – Temporary or permanent leukotrichia (localized white or gray hair) may occur.
Warnings: Do not treat over dysplastic nevi or questionable pigmented lesions. Do not treat over open wounds. Do not treat over or close to tattoos or permanent make-up. Do not treat over or close to metal or electronic implants. Hair removal by lasers or intense pulse light sources can cause increased hair growth in some individuals. Based upon currently available data, the highest risk groups for this response are females of Mediterranean, Middle Eastern, and South Asian heritage treated on the face and neck.
Precautions: Use caution when treating patients with any of the following: History of coagulopathies;History of keloids or hypertrophic scarring; History of herpes – pre-treatment with an antiviral may be indicated History of vitiligo – may cause de-pigmentation; Diabetes – may impede wound healing Metal or electronic implants; Current or recent use of the following medications: Accutane – do not treat if taken in the past 6 months; Gold Therapy – may cause blue-gray discoloration; Anticoagulants – may increase risk of purpura or bruising; Photosensitizing medications/agents. In addition, observe the following precautions: Use caution when treating over hair bearing areas. Laser energy may affect hair growth.Place moist gauze between the lips and teeth if treating near the mouth. Laser energy may affect teeth. Treat at least at least 15 cm (6 in) frompacemakers/ defibrillators. Reaction to metal or electronic implants is unknown. Refer to the Operator Manual to view the laser safety labels of the product.